Conference abstract · 2017
Conference abstractPublished 26 Sep 2016
Circulating epithelial cells: Ready for routine
SIMFO GmbH Bayreuth, Germany
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Circulating epithelial tumor cells (CETC) are cells derived from the primary and metastatic tumor, which persist and re-circulate in the peripheral blood and can lead to the formation of distant metastases. CETC analysis is already used in routine diagnostic to monitor the risk for metastatic relapse and progression in patients with malignant disease. Non-dissipative approaches like maintrac allow the quantitative detection of CETC in the peripheral blood, also of non-metastatic patients. Enumeration and further characterization of CETC can be used as a liquid biopsy for repeated follow-up examinations in a variety of human cancers. During the past 15 years maintrac was used in 13 clinical trials with more than 650 patients. Up to now, approximately 50,000 blood samples of more than 20,000 patients were monitored in routine with maintrac. Increasing numbers of CETC, for example in breast cancer patients during or after chemo and/or maintenance therapy, indicate increased tumor activity with an increased risk of relapse. In contrast, patients with decreasing cell numbers show a good prognosis. At the moment several clinical trials are ongoing, i.e. CETC as a screening tool or as companion diagnostics. We will present new results as well as examples of day to day use.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 13 Jun 2016
Monitoring cancer progression by detecting circulating cancer cells with both epithelial and mesenchymal features
Conference abstract · 2017
Nanoelectromechanical chip (NELMEC), an electromicrofluidic chip to diagnose epithelial and mesenchymal breast circulating tumor cells from leukocytes based on Silicon nanograss electrodes
Conference abstract · 10 Sep 2012
Longitudinal monitoring of EGFR mutation and amplification status in circulating epithelial tumor cells (CETC) of lung cancer patients
Short communication · 2017
Is Circulating Tumor DNA (Ctdna) Use Ready For Prime Time? Applications and Challenges of Ctdna in the Era of Precision Oncology
More from this journal
The newest in Cancer Science & Therapy.
Commentary · 21 Feb 2026
Functional Immune Biomarker Identification in Patients with Breast Cancer
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Stefan Schuster”

